US52635N1037
US52635N1037
LENZ Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 19.088.000 | -- | -- |
| Cost of Revenue | 418.000 | -- | -- |
| Gross Profit | 18.670.000 | -- | -- |
| 109.808.000 | 58.610.000 | 87.4% | |
| Operating Income | -91.138.000 | -58.610.000 | 55.5% |
| Pretax Income | -81.625.000 | -49.768.000 | 64.0% |
| Net Income Common Stockholders | -82.127.000 | -49.769.000 | 65.0% |
| -- | -- | -- | |
| -- | -- | -- |